半岛·综合体育(CHINA)官网-Unified platform

中文 丨 EN
中文 丨 EN

About Us

—

Amoytop Biotech is an innovative biopharmaceutical company in China, specialized in R&D, manufacturing and marketing of regular and long-acting recombinant protein drugs. Focusing on the R&D of immune-related cytokine medicines, Amoytop Biotech is committed to providing better solutions for major diseases including viral hepatitis, malignant tumors and immunotherapy. In the future, Amoytop Biotech will specially focus on CHB (chronic hepatitis B) treatment to achieve breakthroughs in clinical cure.

PRODUCT

—

01

Peginterferon Alfa-2b

Pegylated Recombinant Human Interferon alfa-2b

1st 40kD Y-shape branched PEG modified interferon alfa-2b injection

MORE
02

Molgramostim

Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor

National Medical Insurance, Category B ; Launched in 1997,The first China-made Molgramostim in marke

MORE
03

Filgrastim

Recombinant Human Granulocyte Colony-Stimulating Factor

National Medical Insurance, Category B;Launched in 1999 and awarded as an excellent brand of biologi

MORE
04

Oprelvekin

Recombinant Human Interleukin 11

National Medical Insurance, Category B;Launched in 2005,,National standard bulk supplier of rHuIL-1

MORE

INNOVATING

Research and Innovation

—

Committing to research and innovation of recombinant protein medicines, especially long-acting modification, Amoytop Biotech has established its own research teams and systems that composed of following modules: R&D center, medical development center, manufacturing center and quality center, covering all R&D aspects of innovative medicines from scientific discovery, laboratory trial, pilot trial, preclinical and clinical trial to industrialization. All modules are run and connected through Core Technology Platform and projectization, forming a complete closed loop for R&D cycle.

NEWS

—

2020-02-17

Lead the way to cure chronic hepatitis B: China's first chronic hepatitis B clinical cure summit was

2019年3月17日，全国首个以“乙肝临床治愈”为主题的学术盛会——“慢乙肝临床治愈峰会暨中国派高峰论坛”在厦门隆重举行。本次论坛汇聚了我国病毒性肝炎治疗领域的顶级大咖及300多位肝病临床专家。

CONTACT US

—

Xiamen Amoytop Biotech Co., Ltd.

  • Tel：86 592 6889105/108

    Email： bd.amoytop@gmail.com / international@amoytop.com

    Add：No. 330 Wengjiao Road, Haicang, Xiamen, Fujian, China

    Postcode：361028

  • Join Us：0592-7701210

    Email：hr@amoytop.com

  • Adverse Events Tel：86-592-6889111

    Adverse Events Email：fk@amoytop.com